Summit Tx Capital, L.P. Natera, Inc. Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Natera, Inc. stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 59,359 shares of NTRA stock, worth $8.87 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
59,359Holding current value
$8.87 Million% of portfolio
0.36%Shares
1 transactions
Others Institutions Holding NTRA
# of Institutions
656Shares Held
126MCall Options Held
979KPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA12.4MShares$1.85 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.5MShares$1.57 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.1 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.01 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.55MShares$679 Million3.7% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $14.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...